Marya Gwadz1,2, Charles M Cleland3,4, Robert Freeman5, Leo Wilton6,7, Linda M Collins8, Robert L Hawkins9, Amanda S Ritchie9, Noelle R Leonard3,9, Danielle F Jonas9, Alexis Korman10, Sabrina Cluesman9, Ning He9, Dawa Sherpa9. 1. Center for Drug Use and HIV/HCV Research (CDUHR), New York University School of Global Public Health, New York, NY, USA. marya.gwadz@nyu.edu. 2. New York University Silver School of Social Work, New York, NY, USA. marya.gwadz@nyu.edu. 3. Center for Drug Use and HIV/HCV Research (CDUHR), New York University School of Global Public Health, New York, NY, USA. 4. Division of Biostatistics, Department of Population Health, New York University School of Medicine, New York, NY, USA. 5. Independent Consultant, Brooklyn, NY, USA. 6. Department of Human Development, State University of New York at Binghamton, Binghamton, NY, USA. 7. Faculty of Humanities, University of Johannesburg, Auckland Park 2006, Johannesburg, South Africa. 8. Methodology Center and Department of Human Development and Family Studies, Pennsylvania State University, State College, PA, USA. 9. New York University Silver School of Social Work, New York, NY, USA. 10. New York University School of Medicine, New York, NY, USA.
Abstract
BACKGROUND: Although periods of HIV antiretroviral therapy (ART) discontinuation have deleterious health effects, ART is not always sustained. Yet, little is known about factors that contribute to such ART non-persistence among long-term HIV survivors. The present study applied a convergent parallel mixed-methods design to explore the phenomena of stopping/starting and sustaining ART, focusing on low-socioeconomic status African American or Black and Latino persons living with HIV (PLWH) who face the greatest challenges. METHODS: Participants (N = 512) had poor engagement in HIV care and detectable HIV viral load. All received structured assessments and N = 48 were randomly selected for in-depth interviews. Quantitative analysis using negative binomial regression uncovered associations among multi-level factors and the number of times ART was stopped/started and the longest duration of sustained ART. Qualitative data were analyzed using a directed content analysis approach and results were integrated. RESULTS: Participants were diagnosed 18.2 years ago on average (SD = 8.6), started ART a median five times (Q1 = 3, Q3 = 10), and the median longest duration of sustained ART was 18 months (Q1 = 6, Q3 = 36). Factors associated with higher rates of stops/starts were male sex, transgender identity, cannabis use at moderate-to-high-risk levels, and ART- and care-related stigma. Factors associated with lower rates of stops/starts were older age, more years since diagnosis, motivation for care, and lifetime injection drug use (IDU). Factors associated with longer durations of sustained ART were Latino/Hispanic ethnicity, motivation for ART and care, and recent IDU. Factors associated with a shorter duration were African American/Black race, alcohol use at moderate-to-high-risk levels, and social support. Qualitative results uncovered a convergence of intersecting risk factors for stopping/starting ART and challenges inherent in managing HIV over decades in the context of poverty. These included unstable housing, which contributed to social isolation, mental health distress, and substance use concerns, the latter prompting selling ("diverting") ART. Primarily complementary quantitative and qualitative findings described mechanisms by which risk/protective factors operated and ways PLWH successfully restart and/or sustain ART. CONCLUSIONS: The field focuses substantially on ART adherence, but greater attention to reducing the frequency of ART non-persistence is needed, along with creating social/structural conditions favorable for sustained ART.
BACKGROUND: Although periods of HIV antiretroviral therapy (ART) discontinuation have deleterious health effects, ART is not always sustained. Yet, little is known about factors that contribute to such ART non-persistence among long-term HIV survivors. The present study applied a convergent parallel mixed-methods design to explore the phenomena of stopping/starting and sustaining ART, focusing on low-socioeconomic status African American or Black and Latino persons living with HIV (PLWH) who face the greatest challenges. METHODS: Participants (N = 512) had poor engagement in HIV care and detectable HIV viral load. All received structured assessments and N = 48 were randomly selected for in-depth interviews. Quantitative analysis using negative binomial regression uncovered associations among multi-level factors and the number of times ART was stopped/started and the longest duration of sustained ART. Qualitative data were analyzed using a directed content analysis approach and results were integrated. RESULTS: Participants were diagnosed 18.2 years ago on average (SD = 8.6), started ART a median five times (Q1 = 3, Q3 = 10), and the median longest duration of sustained ART was 18 months (Q1 = 6, Q3 = 36). Factors associated with higher rates of stops/starts were male sex, transgender identity, cannabis use at moderate-to-high-risk levels, and ART- and care-related stigma. Factors associated with lower rates of stops/starts were older age, more years since diagnosis, motivation for care, and lifetime injection drug use (IDU). Factors associated with longer durations of sustained ART were Latino/Hispanic ethnicity, motivation for ART and care, and recent IDU. Factors associated with a shorter duration were African American/Black race, alcohol use at moderate-to-high-risk levels, and social support. Qualitative results uncovered a convergence of intersecting risk factors for stopping/starting ART and challenges inherent in managing HIV over decades in the context of poverty. These included unstable housing, which contributed to social isolation, mental health distress, and substance use concerns, the latter prompting selling ("diverting") ART. Primarily complementary quantitative and qualitative findings described mechanisms by which risk/protective factors operated and ways PLWH successfully restart and/or sustain ART. CONCLUSIONS: The field focuses substantially on ART adherence, but greater attention to reducing the frequency of ART non-persistence is needed, along with creating social/structural conditions favorable for sustained ART.
Entities:
Keywords:
Disparities; HIV antiretroviral therapy; HIV survivorship; Initiation; Mixed methods; Non-persistence; Poverty; Race/ethnicity; Resilience; Substance use
Authors: Bohdan Nosyk; Emanuel Krebs; Xiao Zang; Micah Piske; Benjamin Enns; Jeong E Min; Czarina N Behrends; Carlos Del Rio; Daniel J Feaster; Matthew Golden; Brandon D L Marshall; Shruti H Mehta; Zachary F Meisel; Lisa R Metsch; Ankur Pandya; Bruce R Schackman; Steven Shoptaw; Steffanie A Strathdee Journal: Clin Infect Dis Date: 2020-12-31 Impact factor: 9.079
Authors: Carl A Latkin; Melissa A Davey-Rothwell; Amy R Knowlton; Kamila A Alexander; Chyvette T Williams; Basmattee Boodram Journal: J Acquir Immune Defic Syndr Date: 2013-06-01 Impact factor: 3.731
Authors: V J Felitti; R F Anda; D Nordenberg; D F Williamson; A M Spitz; V Edwards; M P Koss; J S Marks Journal: Am J Prev Med Date: 1998-05 Impact factor: 5.043
Authors: Marya Gwadz; Sabrina R Cluesman; Robert Freeman; Linda M Collins; Caroline Dorsen; Robert L Hawkins; Charles M Cleland; Leo Wilton; Amanda S Ritchie; Karen Torbjornsen; Noelle R Leonard; Belkis Y Martinez; Elizabeth Silverman; Khadija Israel; Alexandra Kutnick Journal: Int J Equity Health Date: 2022-07-16
Authors: Marya Gwadz; Samantha Serrano; Sebastian Linnemayr; Charles M Cleland; Sabrina R Cluesman; Robin M Freeman; Kinsey Kellam; Corey De Stefano; Khadija Israel; Emily Pan Journal: Front Public Health Date: 2022-09-15